Regulating Herbal Medicines in Europe Heribert PITTNER Federal Ministry of Health and Women, Vienna, Austria 8th European Health Forum Gastein 7 October.

Slides:



Advertisements
Similar presentations
EPAA Annual conference November Regulatory acceptance of alternative approaches for pharmaceuticals Jean-Marc Vidal Safety & Efficacy of Human Medicines.
Advertisements

Registration in Europe Current situation and future outlook Thomas K ü rner, M.D. Nippon Boehringer Ingelheim Co., Ltd.
Merton V. Smith, Ph.D., J.D. Director International Programs Center for Veterinary Medicine U.S. Food and Drug Administration Governance of Veterinary.
Unit D/3 – Regulated professions
Introduction to PPDs Regulatory requirements and rationale.
Federal agency for medicines and health products EXCIPIENTS IN THE LABLE AND PACKAGE LEAFLET OF HOMEOPATHIC MEDICINAL PRODUCTS Patricia Bodart – 23 October.
Title, date Mr. Einar Magnússon Director, Department of Pharmaceutical Affairs Ministry for Health.
S4: Market Surveillance Physikalisch-Technische Bundesanstalt Session 4: Market surveillance Peter Ulbig, Harry Stolz Belgrade, 31 October.
I&EHL: EU Pharmaceutical Law André den Exter
The State of Pediatric Clinical Trials in Europe A Regulatory Overview by Virinder Nohria, MD, PhD Presented at ASENT Annual Meeting Dinner Symposium Washington.
EU System for Marketing Authorisation
Knowledge Update Clinical documentation: from preclinical studies to drug registration Split, 12 September 2008.
1 FDA Thailand By HIV Module/Marketing Group Mr. Manaswee Arayasiri.
Product Safety and Market Surveillance Package
1 The European Paediatric Initiative Agnès Saint Raymond, MD Scientific Advice and Orphan Drugs The European Medicines Evaluation Agency.
1. 2 List of content  EMEA STRUCTURE  EMEA MISSION STATEMENT  EMEA COMMITTEE  MANAGEMENT BOARD  COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP)
1 International API Inspection Pilot Program Olivier Gross Scientific Administrator EMEA DIA International Conference Quality of Active Pharmaceutical.
Orphan drug designation in the European Union (EU)
THE HIGHLIGHTS OF DRUG REGULATION IN KENYA. Presentation by: Dr. Joseph K. Yano B.Pharm (Nbi) L.L.B (Moi) Legal Officer Pharmacy and Poisons Board Ministry.
The perspective of the food and drink manufacturing sector Meeting consumer needs Responding to new challenges Dominique TAEYMANS Director Scientific &
Jean-Marc Spieser, 23/09/09 ©2009 EDQM, Council of Europe, All rights reserved 1 Principles of Article 58 - possible support to 3rd countries for licensing.
Terezia Sinkova EFSA The new EU Food Safety Agency.
Dr Xiaorui Zhang Coordinator
Working together with EFSA in making Europe’s food safe Warszawa, 16. April 2013 Cooperation between EFSA and Member States Jacek Postupolski National.
Monograph Development Process for the European Pharmacopoeia: How to participate in the work programme of the European Pharmacopoeia Dr Claude Coune Head.
Principles of quality control of registered medicines, non- registered medicines and counterfeits of medical products Jean-Marc Spieser, Head of Department.
EU Council Directive on Traditional Herbal Medicinal Products Dr. Dairine Dempsey IRISH MEDICINES BOARD for IHTA AGM 23 rd April 2003.
Artemisinin combined medicines, Kampala, February |1 | Training workshop on regulatory requirements for registration of Artemisinin based combined.
International Pharmaceutical Regulation and Compliance Comparisons and Contrasts Lester M. Crawford, PhD.
Meeting for EU Generic Manufacturers and EU MA holders for generic medicines, Copenhagen, 26 November 2009 Generics approved by stringent regulatory authorities:
Paediatric Worksharing CMDh participation Work-sharing in Art 45 and 46 procedures Experiences in Art 29 procedures Presidency meeting 29 September 2011.
E UROPEAN B LOOD D IRECTIVE. D ISCLAIMER I have no official status as a spokesperson for the EU, EC, or Member States I present a personal view of the.
TAIEX Workshop on EU legislation for Veterinary Medicinal Products – Istanbul April 2011 Marketing Authorisation Procedures for Veterinary Medicinal.
Standardization system in the European Union Werner STERK Federal Ministry of Economics and Technology Unit “Standardization, Conformity Assessment, Metrology”
WHO Workshop on Prequalification of Medicines Programme, Abu Dhabi, October, 2010 Regulatory principles reflected in practice of WHO PQP Milan Smid,
Federal agency for medicines and health products EC REGULATION 1901/2006 ON MEDICINAL PRODUCTS FOR PAEDIATRIC USE AND HOMEOPATHIC MEDICINAL PRODUCTS Marie-Anne.
Ivowen Ltd1 Ivowen Limited Preparation and Submission of a Traditional Herbal Medicinal Product Application.
WHO, Almaty 2002 Food Legislation of the European Union and its effect on Slovak legislation1 Food legislation of the European Union and its effect on.
European Aviation Safety Agency Head of Aircraft Product Certification
1. 2 > ˜100 3 >2 000 > Paediatric regulation.
European Patients’ Academy on Therapeutic Innovation Marketing authorisation.
Information outcomes from regulatory processes Regine Lehnert Training workshop: Regulatory requirements for registration of Artemisinin based combined.
European Health Forum Gastein Workshop International Quality Comparisons 6 October 2005 "Measuring the patient's perspective: Current and future work in.
Borderline products Foods or medicines? Martijn Martena, PhD the Netherlands Food and Consumer Product Safety Authority Utrecht, the Netherlands Belgrade.
JMAFF (Chair of Biologicals Quality Monitoring EWG)
EPHA Presentation Healthcare and social services treated equally as estate agents or advertising companies excluded from the Directive or Healthcare and.
Health and Food Safety EU strategy for Pharmaceuticals in the Environment Patrizia Tosetti DG SANTE European Commission China/EU Pharmaceutical Industry.
China EU Pharmaceutical Forum
1 VICH AND VETERINARY MEDICINES AVAILABILITY VICH5 CONFERENCE, OCTOBER 2015, TOKYO VICH AND VETERINARY MEDICINES AVAILABILITY VICH5 CONFERENCE, OCTOBER.
An agency of the European Union Principles for the assessment and authorisation of antimicrobials in the EU VICH Outreach Forum, October 2015 Presented.
THE OFFICE FOR REGISTRATION OF MEDICINAL PRODUCTS, MEDICAL DEVICES AND BIOCIDAL PRODUCTS Responsibility in the handling of medical devices.
Veterinary Products Management and Quality Control System in Thailand : Veterinary Vaccine Tasanee Lorchaivej Workshop on the Veterinary Products.
Current trend of regulation, approval and development of advanced therapy medicinal products in Europe Balázs Sarkadi, Hungarian Academy of Sciences, Budapest,
ICORD 2006 Kerstin Westermark Md, PhD, Assoc. prof. COMP Chairperson.
Implementation of The Russian Pharmacovigilance regulation Alexander Panin State Veterinary and Phytosanitary Surveillance Agency of the Russian Federation.
POST APPROVAL CHANGE MANAGEMENT PROTOCOLS IN THE EUROPEAN UNION
A capacity building programme for patient representatives
Quality of the medicinal products. Drug switching.
Information on Medicinal Products
PAEDIATRIC REGULATION
LITERATURE REVIEW As the pharmaceutical industries throughout the world are moving ahead towards becoming more and more competitive, regulatory agencies.
Multinational collaboration in the Authorisation of VMPs: the EU approach VICH Outreach Forum Tokyo, Nov 2017 Noel Joseph European Commission.
FOOD AND VETERINARY OFFICE
FOODstars Fortified Foods
The Benefits of VICH to Emerging Countries
Prescription-only vs. over-the-counter medicines
The European Pharmacopoeia and Pharmeuropa
THE HIGHLIGHTS OF DRUG REGULATION IN KENYA
THE EU LEGAL FRAMEWORK ON EMPLOYEE INVOLVEMENT
SID & GP MINPROMTORG OF RUSSIA Corporate Communication Center
Presentation transcript:

Regulating Herbal Medicines in Europe Heribert PITTNER Federal Ministry of Health and Women, Vienna, Austria 8th European Health Forum Gastein 7 October 2005

Regulating Herbal Medicines in Europe Until 2004: Different national regulations 31 March 2004: Directive 2004/24/EC as regards traditional herbal medicinal products

Traditional herbal medicinal product: Criteria (1) Indications without prescription Specified strength and dosage Oral, external and/or inhalation preparation Period of traditional use has elapsed: - at least 30 years, including at least 15 years within the European Union

Traditional herbal medicinal product: Criteria (2) Data are sufficient: - Not harmful in the specified conditions of use - Pharmacological effects or efficacy are plausible on the basis of long-standing use and experience

Directive 2004/24/EC Vitamins and minerals are allowed in traditional herbal medicinal products, provided that their action is ancillary to that of the herbal medicinal product

Documents for the application of traditional herbal medicinal products Results of pharmaceutical tests Summary of Product Characteristics Information relating to combinations Registrations in other countries Evidence to the medicinal use of at least 30 / 15 years

Labelling / Package Leaflet / Advertisement "Traditional herbal medicinal product for use in specified indication(s) exclusively based upon long-standing use"

Scientific Committees at EMEA (European Medicines Agency) CHMP (formerly CPMP): Human Medicines CVMP: Veterinary Medicines COMP: Orphan Products HMPC: Herbal Medicinal Products

HMPC (Committee for Herbal Medicinal Products) First Meeting on September 23, 2004: Chair elected: Konstantin Keller (Germany) Vice chair elected: Heribert Pittner (Austria) Meetings at EMEA every other month for 2 to 3 days

HMPC (Committee for Herbal Medicinal Products) 25 delegates and 25 alternates (1 per each EU Member State) Members from Norway and Iceland (with separate counting of votes) + up to 5 additional co-opted members

Tasks of the HMPC Check evidence of long-term medicinal use of a traditional herbal medicinal product Prepare lists of herbal substances for registration as traditional herbal medicinal products Establish community monographs for traditional and other herbal medicinal products Referral procedures for traditional herbal medicinal products Opinions on herbal substances in other medicinal products Any other task due to Community Law

Community herbal monographs (1) HMPC shall establish monographs for Herbal medicinal products with well- established medicinal use (= more than 10 years) Traditional herbal medicinal products

Community herbal monographs (2) Definition: Document the purpose of which is to provide a scientific summary of all data available on the safety and efficacy of a herbal substance / herbal preparation intended for medicinal use

Community herbal monograph: Sources ESCOP Monographs (European Scientific Cooperative on Phytotherapy) WHO Monographs European Pharmacopoeia Other Pharmacopoeias Any Published Literature

Goals of Regulation of Herbal Medicinal Products in the European Union Harmonisation of requirements on quality, safety and efficacy for herbal medicinal products Pharmacovigilance for herbal medicinal products Facilitation of free movement of safe herbal medicinal products within the European Union

Crucial issues to HMPC Setting the borderline between well-established use and traditional use Setting the borderline between traditional herbal medicinal products and food supplements